Bladder cancer prognosis

Richard Bryan (Inventor), Douglas Ward (Inventor)

Research output: Patent

4 Citations (Scopus)
51 Downloads (Pure)

Abstract

The present invention concerns the use of protein biomarkers for use in facilitating in the prognosis and/or treatment regime of bladder cancer. In particular, the invention relates to the use of shed protein fragments, such as fragments of Epithelial cell adhesion molecule (EpCAM) and/or epidermal growth factor receptor (EGFR) detected in a sample of urine, as biomarkers for use in facilitating the prognosis and/or treatment regime of urothelial bladder cancer.
Original languageEnglish
Patent numberWO/2016/083832
IPCG01N 33/574 (2006.01), G01N 33/68 (2006.01)
Priority date28/11/14
Publication statusPublished - 2 Jun 2016

Fingerprint

Dive into the research topics of 'Bladder cancer prognosis'. Together they form a unique fingerprint.

Cite this